Skip to main content
. 2022 Oct 21;25(Suppl 6):e26009. doi: 10.1002/jia2.26009
Abstract O46 – Table 1. Change in total lymphocyte counts and CD4+ T‐cell counts in treatment‐naïve participants with HIV‐1, MK‐8591‐011 parts 1 and 2 (through week 72).
Total lymphocyte counts (109 cells/L)
Treatment group N Mean % change from baseline (95% CI)a
DOR/3TC/TDF 22 15.9 (2.0, 29.9)
ISL 0.25 mg + DOR 100 mg (+/‐ 3TC) 19 20.5 (4.3, 36.6)
ISL 0.75 mg + DOR 100 mg (+/‐ 3TC) 19 ‐0.4 (‐14.9, 14.1)
ISL 2.25 mg + DOR 100 mg (+/‐ 3TC) 16 ‐15.9 (‐31.9, 0.1)
CD4+ T‐cell counts (cells/mm3)
Treatment group N Mean % change from baseline (95% CI)a
DOR/3TC/TDF 22 60.1 (40.2, 80.0)
ISL 0.25 mg + DOR 100 mg (+/‐ 3TC) 19 79.8 (50.0, 109.6)
ISL 0.75 mg + DOR 100 mg (+/‐ 3TC) 18 47.1 (26.1, 68.2)
ISL 2.25 mg + DOR 100 mg (+/‐ 3TC) 16 24.0 (4.7, 43.4)

aThe within‐group 95% CIs were calculated based on the t‐distribution.